Publication | Open Access

A Randomized, Double-Blind, Multicenter Study Comparing a Starting Dose of 100 IU or 200 IU of Recombinant Follicle Stimulating Hormone (Puregon�) in Women Undergoing Controlled Ovarian Hyperstimulation for IVF Treatment

InfertilityUrologyFertilityFemale InfertilityReproductive HealthIvf TreatmentGynecologyFemale Reproductive SystemReproductive MedicineHuman ReproductionMulticenter StudyPublic HealthMedicineIn Vitro FertilizationOvarian HormoneWomen's HealthOvarian Cancer